Kraljević Pavelić, S., Krpan, D., Žuvić, M., Eisenwagen, S. i Pavelić, K. (2022). Clinical Parameters in Osteoporosis Patients Supplemented With PMA-Zeolite at the End of 5-Year Double-Blinded Clinical Trial. Frontiers in Medicine, 9., 1-10. doi: 10.3389/fmed.2022.870962
Kraljević Pavelić, Sandra, et al. "Clinical Parameters in Osteoporosis Patients Supplemented With PMA-Zeolite at the End of 5-Year Double-Blinded Clinical Trial." Frontiers in Medicine, vol. 9, 2022, str. 1-10. https://doi.org/10.3389/fmed.2022.870962
Kraljević Pavelić, Sandra, Dalibor Krpan, Marta Žuvić, Sandra Eisenwagen i Krešimir Pavelić. "Clinical Parameters in Osteoporosis Patients Supplemented With PMA-Zeolite at the End of 5-Year Double-Blinded Clinical Trial." Frontiers in Medicine 9 (2022): 1-10. https://doi.org/10.3389/fmed.2022.870962
Kraljević Pavelić, S., et al. (2022) 'Clinical Parameters in Osteoporosis Patients Supplemented With PMA-Zeolite at the End of 5-Year Double-Blinded Clinical Trial', Frontiers in Medicine, 9, str. 1-10. doi: 10.3389/fmed.2022.870962
Kraljević Pavelić S, Krpan D, Žuvić M, Eisenwagen S, Pavelić K. Clinical Parameters in Osteoporosis Patients Supplemented With PMA-Zeolite at the End of 5-Year Double-Blinded Clinical Trial. Frontiers in Medicine [Internet]. 27.06.2022. [pristupljeno 26.08.2024.];9:1-10. doi: 10.3389/fmed.2022.870962
S. Kraljević Pavelić, D. Krpan, M. Žuvić, S. Eisenwagen i K. Pavelić, "Clinical Parameters in Osteoporosis Patients Supplemented With PMA-Zeolite at the End of 5-Year Double-Blinded Clinical Trial", Frontiers in Medicine, vol. 9, str. 1-10, Lipanj 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:346820. [Citirano: 26.08.2024.]